Related Experiment Video
Updated: May 27, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?
Aneesh Srivastava1, Rajesh Bansal, Alok Srivastava
1Department of Urology and Renal Transplant, SGPGIMS, Lucknow, India.
Insights
Percutaneous nephrolithotomy (PCNL) is a safe and effective treatment for kidney stones in patients with autosomal dominant polycystic kidney disease (ADPKD). This procedure offers a high success rate despite anatomical challenges and associated chronic kidney disease.
Area of Science:
- Nephrology
- Urology
- Surgical Innovation
Background:
- Nephrolithiasis is a common complication in autosomal dominant polycystic kidney disease (ADPKD).
- Managing kidney stones in ADPKD patients presents unique challenges due to cystic changes and altered renal anatomy.
- Patients with ADPKD often have comorbid chronic kidney disease, increasing procedural risks.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous nephrolithotomy (PCNL) for treating nephrolithiasis in patients with ADPKD.
- To assess the outcomes of PCNL in ADPKD patients with varying degrees of chronic kidney disease.
Main Methods:
- A retrospective analysis of 22 ADPKD patients who underwent PCNL for renal calculi between 2000 and 2010.
- Patients were stratified into two groups based on preoperative serum creatinine levels (≤1.5 mg% and >1.5 mg%).
Main Results:
- PCNL was performed on 25 renal units with an overall stone clearance success rate of 88%.
- Mean stone burden was 2.4 cm; two patients required repeat PCNL and one needed ESWL.
- Postoperative serum creatinine improved in patients with higher preoperative levels; 13% required blood transfusion and 18% experienced fever, with no angioembolization needed.
Conclusions:
- Percutaneous nephrolithotomy (PCNL) is a safe and effective treatment option for nephrolithiasis in ADPKD patients.
- The procedure demonstrates good stone clearance rates despite the complex anatomy associated with ADPKD.
- PCNL can be safely performed in ADPKD patients with chronic kidney disease, with manageable complication rates.
Purpose:
Nephrolithiasis is common in patients with autosomal dominant polycystic kidney disease (ADPKD). Percutaneous management of nephrolithiasis is challenging because of a large number of parenchymal cysts and distorted calyceal anatomy. These patients also have varying grades of chronic kidney disease and are at increased risk of bleeding, which further increases the challenge. The objective of the study is to study the efficacy and safety of PCNL in ADPKD.
Materials And Methods:
We retrospectively analyzed twenty-two patients of ADPKD with renal calculi managed by percutaneous nephrolithtomy (PCNL) from January 2000 to January 2010. Patients were divided into two groups: group I (serum creatinine ≤ 1.5 mg%), group II (serum creatinine >1.5 mg%).
Results:
PCNL was done in 25 renal units among 22 patients. Sixteen patients had chronic kidney disease, and the average stone burden was 2.4 cm ± 0.8 cm. The overall success rate (complete stone clearance/residual fragments <4 mm) was 88% (22/25). Two patients required relook PCNL for residual stone and one required ESWL for the incomplete clearance. Mean preoperative serum creatinine in group I was 0.9 ± 0.1 mg% and in group II 3.1 ± 1.2 mg%. There was improvement in serum creatinine in group II (1.4 ± 0.5 mg%) postoperatively. Three patients required blood transfusion (13%) and four patients had fever postoperatively (18%). None of the patients required angioembolization.
Conclusion:
Despite the distorted calyceal anatomy and associated chronic kidney disease, PCNL is safe and effective in managing nephrolithiasis in polycystic kidney disease.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease III: Interprofessional Care
